PLASMINOGEN-ACTIVATOR INHIBITOR-2 EXPRESSION IN INFLAMED APPENDIX

被引:11
|
作者
WHAWELL, SA
THOMPSON, EM
FLEMING, KA
THOMPSON, JN
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT SURG,LONDON,ENGLAND
[2] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOPATHOL,LONDON W12 0HS,ENGLAND
[3] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND
基金
英国惠康基金;
关键词
PLASMINOGEN ACTIVATOR INHIBITOR; APPENDICITIS; IN SITU HYBRIDIZATION;
D O I
10.1111/j.1365-2559.1995.tb00295.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Plasminogen activator inhibitors are thought to be responsible for the abolition of fibrinolytic activity in inflamed peritoneum, This reduction in the fibrin clearing capacity of the peritoneum promotes the formation of intra-abdominal adhesions, High concentrations of plasminogen activator inhibitor-2 (PAI-2) have been previously found in inflamed peritoneal tissue using immunoassays, but it is undetectable in normal peritoneum, The aim of this study was to localize plasminogen activator inhibitor-2 production in tissue by in situ mRNA hybridisation. Sections of normal and inflamed human appendix were hybridised with a digoxigenin labelled cDNA probe, In normal appendix staining was confined to macrophages in the mucosa. Macrophage staining was also seen in inflamed tissue but with a wider distribution throughout the appendix wall. PAI-2 was also localized to mesothelial cells of inflamed but not normal appendix, Cell identities were confirmed using immunohistochemistry directed against cell specific markers, Staining was absent from control slides incubated with plasmid DNA or PAI-2 probe following ribonuclease digestion, The identification of the cells expressing the PAI-2 gene in peritoneum increases our understanding of the pathophysiological process leading to fibrin deposition within the abdomen during peritonitis.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 50 条
  • [31] PLASMINOGEN-ACTIVATOR INHIBITOR-2 - PROGNOSTIC RELEVANCE IN 1012 PATIENTS WITH PRIMARY BREAST-CANCER
    FOEKENS, JA
    BUESSECKER, F
    PETERS, HA
    KRAINICK, U
    VANPUTTEN, WLJ
    LOOK, MP
    KLIJN, JGM
    KRAMER, MD
    [J]. CANCER RESEARCH, 1995, 55 (07) : 1423 - 1427
  • [32] PLASMINOGEN-ACTIVATOR INHIBITOR-2 AND ALPHA-FETOPROTEIN IN VARIOUS LIVER-DISEASE STATES
    OZYILKAN, E
    SIMSEK, H
    OZDEMIR, O
    SIVRI, B
    KIRAZLI, S
    TELATAR, H
    [J]. THROMBOSIS AND HAEMOSTASIS, 1992, 68 (03) : 374 - 374
  • [33] THE HUMAN GENE FOR PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PA12) EXHIBITS AN ECORI RFLP
    VANDENBERG, EA
    LECLERCQ, E
    KOOISTRA, T
    FRANTS, RR
    BAKKER, E
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (09) : 2837 - 2837
  • [34] Suppression of keratinocyte proliferation by plasminogen activator inhibitor-2
    Hibino, T
    Matsuda, Y
    Takahashi, T
    Goetinck, PF
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (01) : 85 - 90
  • [35] INTERLEUKIN-4 SUPPRESSES PLASMINOGEN-ACTIVATOR INHIBITOR-2 FORMATION IN STIMULATED HUMAN MONOCYTES
    HAMILTON, JA
    WHITTY, GA
    LAST, K
    ROYSTON, AK
    HART, PH
    BURGESS, DR
    [J]. BLOOD, 1992, 80 (01) : 121 - 125
  • [36] POSSIBLE ROLE OF PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN THE PREVENTION OF THE METASTASIS OF GASTRIC-CANCER TISSUES
    NAKAMURA, M
    KONNO, H
    TANAKA, T
    MARUO, Y
    NISHINO, N
    AOKI, K
    BABA, S
    SAKAGUCHI, S
    TAKADA, Y
    TAKADA, A
    [J]. THROMBOSIS RESEARCH, 1992, 65 (06) : 709 - 719
  • [37] The role of plasminogen activator inhibitor-2 in pneumococcal meningitis
    Nina C. Teske
    Joo-Yeon Engelen-Lee
    Susanne Dyckhoff-Shen
    Hans-Walter Pfister
    Matthias Klein
    Diederik van de Beek
    Carsten K. Kirschning
    Uwe Koedel
    Matthijs C. Brouwer
    [J]. Acta Neuropathologica Communications, 10
  • [38] PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND INHIBITOR-2 ARE TUMOR NECROSIS FACTOR CACHECTIN-RESPONSIVE GENES
    MEDCALF, RL
    KRUITHOF, EKO
    SCHLEUNING, WD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (02): : 751 - 759
  • [39] Expression of plasminogen activator inhibitor-2 (PAI-2) during keratinocyte differentiation
    Kim, C.
    Jang, S.
    Sohn, K.
    Lee, K.
    Yoon, T.
    Seo, Y.
    Park, J.
    Lee, J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S73 - S73
  • [40] INTRAOCULAR PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) LEVELS IN PREMATURE-INFANT EYES
    TRESE, M
    ORGEL, I
    HARTZER, M
    WILLIAMS, GA
    CHAPMAN, C
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1085 - 1085